O

Oncologie

21 employees

OncXerna Therapeutics offers precision medicine using an innovative RNA-based biomarker platform.

Basic info

Industry

biotechnology research

Sectors

Precision Medicine
Biotechnology
Pharmaceutical
Biopharma
Biomarker
Medical Device
Health Care
Biopharmaceutical
Oncology

Date founded

2018

Funding rounds raised

Total raised

$80M

from 6 investors over 6 rounds

O

Oncologie raised $30M on March 3, 2022

Investors: Company K Partners

O

Oncologie raised $80M on June 10, 2019

Investors: Korea Investment Partners and Nan Fung Life Sciences

O

Oncologie raised $17M on June 7, 2018

Investors: 火山石投资 Volcanics Venture, Nan Fung Life Sciences and CMB International

FAQ